来源：新浪证券-红岸工作室 三博脑科医院管理集团股份有限公司（以下简称"三博脑科"）近日发布关于持股5%以上股东减持股份 的预披露公告，股东TBP 3Doctors (HK) Limited计划减持公司股份。 减持股东及股份情况 TBP 3Doctors (HK) Limited目前持股数量为31,205,425股，占剔除公司回购专用账户股份数量后总股本 的15.37%，其所持股份全部为无限售条件流通股。股份来源为公司首次公开发行股票并上市前持有的 股份以及该等股份上市后资本公积金转增股本取得的股份。 减持计划详情 减持数量及占比：计划减持6,089,694股，占剔除公司回购专用账户股份数量后总股本的3.00%。其中， 通过集中竞价方式减持不超过2,029,898股（占剔除公司回购专用账户股份数量后总股本的1.00%），通 过大宗交易方式减持不超过4,059,796股（占剔除公司回购专用账户股份数量后总股本的2.00%）。若计 划减持期间内有派息、送股等除权除息事项，减持股份数将相应进行调整。 减持期间：自本公告披露之日起15个交易日后的3个月内。 减持价格：根据减持时的市场价格确定，并根据集中竞价、大宗交易 ...

Group 1 - The core objective of the technical support activity is to enhance the service capabilities and academic influence of medical technology departments through teaching, research, and discipline development [1] - The focus areas of the initiative include the solidification treatment of liver and kidney cysts, microwave ablation of thyroid nodules, and microwave ablation of liver tumors [1] - The "three-dimensional empowerment system" will provide hands-on surgical demonstrations, multidisciplinary perioperative discussions, and the establishment of standardized technical pathways to boost the development of interventional ultrasound in the Zibo region [1] Group 2 - The initiative allows local residents in Zibo and surrounding areas to access top-tier diagnostic and treatment services, aligning with the hospital's commitment to prioritizing public health and distributing quality medical resources [3] - The Zibo Traditional Chinese and Western Medicine Hospital plans to continue deepening technical collaboration and exchanges to enhance the clinical application level of minimally invasive ablation technology [3] - Professor Han Zhiyu will periodically visit the Zibo Traditional Chinese and Western Medicine Hospital for consultations and surgeries, encouraging patients with relevant treatment needs to follow the hospital's public account for updates [3]

Core Points - The hospital acknowledged the existence of a medical dispute regarding a patient's CT imaging error and expressed sincere apologies [1] - The hospital conducted an investigation following complaints from the patient's family about a misdiagnosis due to incorrect imaging [1] - The hospital has communicated and negotiated with the patient and family, and all subsequent tests showed no abnormalities [1] Investigation and Response - The hospital organized relevant departments to investigate the inconsistency in CT examination information [1] - The hospital has committed to further investigations and strict handling of the responsible departments and personnel [1] - The hospital emphasized its commitment to patient-centered care and will enhance medical quality and safety management to prevent similar incidents in the future [1]

胸心外科主任陈晓军于2025年7月前往浙江大学医学院附属邵逸夫医院心外科，跟随国内著名心脏外科专家钱希明教授团队进行 为期半个月的深入学习。学成归来后，陈晓军主任带回国际先进的心脏外科管理理念，并引进前沿技术。 2025/08/13 wisonic 68 圣 [ 结束检查 P7-3T-H(D) TEE Labat SE AP100 MI0.4 TIB0.20 9:42:06 Pat T 37°C TEE T 40.8°C = 术前 180 0 53 10 12 齐鲁晚报.齐鲁壹点王文彬通讯员刘超杜晓萍 wisome LVLJ/VO/ 1. [ـ] 结束检查 P7-3T-H(D) TEE 10:52:33 AP100 MI0.4 TIB0.26 Labat SE Pat T 37°C 3 TEE T 41.7℃ 180 0 术中 5. . S 10 8月13日，滨州市中心医院胸心外科独立完成医院首例改良食道超声(TEE)引导下卵圆孔(PFO)介入封堵术。该手术的成功开展， 标志着医院心脏外科在结构性心脏病微创介入治疗领域取得重大突破，实现了该技术的自主化、精准化应用。 手术患者为一名老年女性，术前检查显示其PF ...

Core Insights - Samsung Medical has 38 hospitals, including 32 rehabilitation hospitals, focusing on building a chain of rehabilitation hospitals with a specialty in critical rehabilitation [1] - The subsidiary Ningbo Mingzhou Hospital is a tertiary Class B general hospital with over 40 departments, including dentistry, ophthalmology, and medical aesthetics [1] - The company, headquartered in Ningbo, is part of the AUX Group and operates in manufacturing, medical services, and financial leasing [1] - In Q1 2025, the company achieved revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit attributable to shareholders of 489 million yuan, up 34.33% year-on-year [1]

Investment Rating - The report does not explicitly state an investment rating for the industry, but it indicates a positive trend in the pharmaceutical and biotechnology sector with a weekly increase of 3.08% [3][8]. Core Insights - The pharmaceutical and biotechnology sector outperformed the Wind All A index and the CSI 300 index during the week of August 11 to August 15, with notable gains in medical research outsourcing (7.77%), hospitals (5.59%), and medical consumables (4.47%) [3][8]. - The upcoming launch of the commercial insurance innovative drug directory is expected to activate the domestic high-end payment market for innovative drugs, with 121 drug names passing preliminary review [3][8]. - The World Conference on Lung Cancer (WCLC) will take place from September 6 to 9, showcasing significant research advancements in lung cancer, with domestic research playing an increasingly important role [3][8]. Market Weekly Review - The pharmaceutical and biotechnology sector rose by 3.08%, outperforming the Wind All A index (2.95%) and the CSI 300 index (2.37%) [3][8]. - Medical research outsourcing, hospitals, and medical consumables led the sector's gains, while offline pharmacies, blood products, and medical circulation experienced declines [3][8]. - Notable individual stock performances included Sino Medical (69.1%), Innovation Medical (51.5%), and Guangsheng Tang (40.7%) for gains, while *ST Suwu (-16.8%), ST Sansheng (-15.2%), and Nanhua Biological (-14.2%) faced significant losses [3][11]. Industry News and Key Company Announcements - The National Medical Insurance Administration announced the preliminary review of the 2025 National Basic Medical Insurance drug directory and the commercial insurance innovative drug directory [3][13]. - Novo Nordisk received accelerated FDA approval for its therapy Wegovy for treating non-alcoholic steatohepatitis (NASH) [3][13]. - Yunnan Baiyao approved a full acquisition of An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for 660 million RMB to enhance its traditional Chinese medicine business [3][15]. - Insmed's DPP1 inhibitor Brensocatib received FDA approval for treating non-cystic fibrosis bronchiectasis [3][14].

Core Insights - The new campus of Guangming District People's Hospital is expected to begin trial operations by the end of this year, with a total construction area of approximately 340,000 square meters and the capacity to provide 1,500 beds [1] - The hospital aims to enhance the region's emergency and critical care capabilities and contribute to the establishment of an integrated health ecosystem in Guangming Science City [1][2] Group 1 - The new hospital campus is a significant milestone for Guangming District People's Hospital, which has evolved from two rudimentary health posts in 1952 to a comprehensive hospital with over 50 community health centers and an annual patient volume exceeding 4.5 million [1][2] - The hospital has achieved several milestones, including recognition as a national-level chest pain center and heart failure center, and has maintained an A-level quality in medical data [2] - The hospital's innovative "1234" scientific and educational integration system includes the establishment of one national drug trial base, two translational research bases, three scientific and educational platforms, and four talent training bases [2] Group 2 - The opening of the new campus and collaboration with Shenzhen University of Technology will focus on building five critical care centers and seven academic clusters, aiming for breakthroughs in key disciplines at the municipal level [2]

Core Viewpoint - The statement from the hospital emphasizes that the online videos distorting the facts about the medical incidents are malicious and unfounded, asserting the hospital's commitment to protecting its medical staff's rights [1]. Summary by Relevant Sections Incident Overview - The hospital responded to allegations from netizens regarding a patient’s death due to "violating contraindications" and "altering medical records," claiming that the videos misrepresent the facts and create significant distress for the medical staff [1]. Patient Background - The patient involved was an elderly individual with over 20 years of hypertension and diabetes, whose family delayed seeking medical help for two days after symptoms appeared, which severely impacted the treatment outcome [1]. Medical Treatment and Outcome - The hospital reported that the patient initially improved under treatment but later experienced a critical condition due to a brain aneurysm rupture, which was deemed an unpredictable risk factor [1]. Legal and Ethical Stance - The hospital maintains that it will pursue legal action against those spreading false information and has offered to cover the costs for medical accident assessments, which were declined by the complainants [1]. Call for Rational Dispute Resolution - The hospital urges the involved parties to cease spreading misinformation and to resolve disputes through formal channels such as medical assessments and legal proceedings [1].

Company Overview - Guangdong Squirrel Hospital Management Co., Ltd. has been established with a registered capital of 20 million RMB [1] - The legal representative of the company is Li Bo, and it is wholly owned by Guangdong Squirrel Hospital Investment Co., Ltd. [1] Business Scope - The company's business scope includes enterprise headquarters management, technical services, development, consulting, communication, transfer, and promotion [1] - It also engages in investment activities using its own funds and hospital management, operating independently within the limits of its business license [1] Registration Details - The company is registered in Zhuhai, located at 868 Hong Kong-Macao Avenue, Hengqin [1] - It is classified as a limited liability company with a natural person investment or holding [1] - The business registration is valid until August 15, 2025, with no fixed term thereafter [1]

据了解，为了支撑这项服务，河南大学淮河医院投入医保终端设备200台，改造自助机40台，配备床旁移动结 算终端110台。 "刷脸就医服务集便捷性和科技感于一体，有效提升了患者就医体验，解决了患者忘记带卡、老年群体不会使 用智能手机等就医痛点，真正做到了'让数据多跑路、让群众少跑腿'。"省卫生健康委相关负责人说，这一服 务模式不仅是技术升级，更是服务理念的革命，鼓励全省更多医院推广实施。（记者 李晓敏） 河南大学淮河医院北院区门诊一楼，患者在刷脸结算。于蒙 摄 责任编辑： 杨露露 随后在诊区，她依次体验了"刷脸签到—医生面诊—检查开单—刷脸支付"的就医流程。"太方便了！"黄女士 高兴地说，"以前忘带卡就得回家取，现在连手机都不用掏，看完病直接走人，医保结算自动完成。" 河南大学淮河医院相关负责人介绍，该院的全流程"刷脸就医"模式包括建档、挂号、就诊、检查、取药、医 保结算、入院办理、出院结算、打印报告等就诊全流程，通过医保终端进行人脸识别，实现就医全流程业 务。 忘带医保卡、手机没电、不会操作智能设备……这些困扰患者就医的"老大难"问题，在河南大学淮河医院已 成为历史。该院创新推出的全流程刷脸就医服务，让患者仅凭 ...